viewEden Research PLC

Eden Research fungicide granted 'emergency use' authorisation in France

Sean Smith, chief executive of Eden, said this is "excellent news", supporting the further growth of Mevalone sales

The emergency use approval is first authorisation for the use of Mevalone on apples

Eden Research PLC's (LON:EDEN) fungicide, Mevalone, has been granted 120-day "emergency use" authorisation in France for the treatment of storage diseases on apples.

The biopesticide supplier’s commercial partner, Sumi Agro, has been selling Mevalone in France since receiving approval for the sale and use of the product for the treatment of botrytis on table and wine grapes in January 2017.

Eden said the emergency use approval respresents the first authorisation for the use of Mevalone on apples and for the treatment of post-harvest storage diseases.

READ: Eden Research partner make first sales in Italy of breakthrough bio-pesticide

Emergency authorisations are granted in the European Union to meet the requirements of growers in the absence of suitable commercially-available alternatives.  

Sumi Agro will sell Mevalone to apple producers, which will apply the fungiside just before harvest. 

France is one of the top 10 producers of apples globally and is the third largest producer in Europe. 

Sean Smith, chief executive of Eden, said: "This is excellent news supporting the further growth of Mevalone sales as it represents a major new use on an important crop for the treatment of diseases that affect the shelf life of apples. 

“Extending the shelf life of any produce is an impactful way of helping to reduce food chain costs and food waste.

"Whist this derogation is valid until the 21st of November 2019, it is a useful illustration of the importance placed by the authorities on the introduction of new, sustainable crop protection products that meet consumer demand for safe foods that are free from pesticide residues.”

Smith said the company is working actively with Sumi Agro to gain full authorisation of Mevalone for use in the treatment of pome fruit storage disease.

Quick facts: Eden Research PLC

Price: 7.75 GBX

Market: AIM
Market Cap: £29.48 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Eden Research PLC named herein, including the promotion by the Company of Eden Research PLC in any Content on the Site, the Company receives...


Eden Research says 'good first half is encouraging sign' as company gets set...

Eden Research PLC's (LON:EDEN) Sean Smith talks to Proactive London about the first half of 2020 which saw the company make progress with its new, effective insecticide products. Half-year revenue nudged up to £746,000 from £581,000 in the first half of 2019. Smith goes on to explain how the...

1 month, 1 day ago

2 min read